Search results
Gilead Sciences Target of Unusually High Options Trading (NASDAQ:GILD)
ETF DAILY NEWS· 2 days agoGilead Sciences, Inc. (NASDAQ:GILD – Get Free Report) saw unusually large options trading on Friday. Gilead Sciences
American Trust Has $2.95 Million Holdings in Gilead Sciences, Inc. (NASDAQ:GILD)
ETF DAILY NEWS· 2 days agoAmerican Trust lessened its holdings in shares of Gilead Sciences, Inc. (NASDAQ:GILD – Free Report) by 2.7% during the fourth quarter, according to the ...
Sunpointe LLC Acquires New Position in Gilead Sciences, Inc. (NASDAQ:GILD)
ETF DAILY NEWS· 3 days agoSunpointe LLC acquired a new stake in Gilead Sciences, Inc. (NASDAQ:GILD – Free Report) during the fourth quarter, Holdings Channel reports. The firm acquired ...
Gilead Sciences (GILD) Stock Dips While Market Gains: Key Facts
Zacks· 5 days agoFree Report) closed at $63.56 in the latest trading session, marking a -1.21% move from the prior day. The stock trailed the S&P 500, which registered a daily gain of 0.23%. The HIV and hepatitis ...
GLOBALT Investments LLC GA Purchases Shares of 43,969 Gilead Sciences, Inc. (NASDAQ:GILD)
ETF DAILY NEWS· 2 days agoGLOBALT Investments LLC GA purchased a new position in shares of Gilead Sciences, Inc. (NASDAQ:GILD – Free Report) during the fourth quarter, according ...
Gilead Sciences, Inc. (GILD) to Issue Quarterly Dividend of $0.77 on June 27th
ETF DAILY NEWS· 5 days agoGilead Sciences, Inc. (NASDAQ:GILD – Get Free Report) announced a quarterly dividend on Tuesday, April 23rd, Zacks reports. Stockholders of record on Friday ...
Gilead Sciences (GILD) Stock Dips While Market Gains: Key Facts
Zacks via Yahoo Finance· 4 days agoGilead Sciences (GILD) closed at $63.56 in the latest trading session, marking a -1.21% move from...
Gilead Sciences Jumps After Its Weight-Loss Drug Emerges From Under The Radar
Investor's Business Daily· 3 days agoGilead stock jumped Friday after surprising Wall Street with preclinical test results for an...
APAC leaps ahead in adoptive cell therapy space
Clinical Trials Arena via Yahoo Finance· 3 hours agoBlockbuster adoptive cell therapies such as Novartis’ CAR-T therapy Kymriah (tisagenlecleucel), and Gilead Sciences’ and Daiichi Sankyo’s Yescarta...
Gilead Stock Gains. It’s Trying to Get Into the Obesity Drug Game.
Barrons.com· 3 days agoGilead Sciences stock was climbing Friday on hopes that it would get into the obesity-drug game....
